1. Jackson JA, Kleerekoper M, Osteoporosis in men: diagnosis, pathophysiology and prevention. Medicine 1990,69:52-137
2. Orwoll ES, Klein RF, Osteoporosis in men. Endocr Rev 1995,16:87-115
3. Khosla S, Lufkin EG, Hodgson SF, Fitzpatrick LA, Melton LJ, Epidemiology and clinical features of osteoporosis in young individuals. Bone 1994,15:5-551
4. Seeman E, The dilemma of osteoporosis in men. Am J Med 1995,98:76-88
5. Kelepouris N, Harper K, Gannon F, Kaplan F, Haddad JG, Severe osteoporosis in men. Ann Intern Med 1995,123:60-452
6. Kurland ES, Rosen CF, Comsan F, Mcmahon D, Chan F, Shane E, et al, Insulin like growth factor-1 in men with idiopathic osteoporosis. Journal of Clinical Endocrinology and Metabolism 1997,82:805-2799
7. Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT, Slootweg MC, Growth hormone and bone. Endocrine Reviews 1998,19:55-79
8. Russell-Aulet M, Shapiro B, Jaffe CA, Gross MD, Barkan AL, Peak bone mass in young healthy men is correlated with the magnitude of endogenous growth hormone secretion. Journal of Clinical Endocrinology and Metabolism 1998,83:8-3463
9. Krasik D, Rosen CJ, Hannan MT, Broe KE, Dawson Hughes D, Gagnon DR, et al, Insulin like growth factor binding proteins 4 and 5 and bone mineral density in elderly men and women. Calcif Tissue Int 2002,71:8-323
10. Hock JM, Centrella M, Canalis E, Insulin- like growth factor 1 has independent effects on bone matrix formation and cell replication. Endocrinology 1988,122:60-254
11. Marcelli C, Yates AJ, Mundy GR, In vivo effects of human recombinant transforming growth factor beta on bone turnover in normal mice. Journal of Bone Mineral Research 1990,5:96-1087
12. Baxter RC, Circulating binding proteins for the insulin-like growth factors. Trends Endocrinol Metab 1993,4:6-91
13. Corpas E, Harman SM, Blackman MR, Serum IGF-binding protein-3 is related to IGF-1, but not to spontaneous GH release, in healthy old men. Horm Metab Res 1992,24:5-543
14. Conover CA, Glycosylation of insulin-like growth factor binding protein-3 (IGFBP-3) is not required for potentiation of IGF-1 action: Evidence for processing of cell-bound IGFBP-3. Endocrinology 1992,129:68-3259
15. Barrett-Connor E, Goodman-Gruen D, Gender differences in insulin like growth factor and bone mineral density association in old age: the Rancho Bernardo study. J Bone Miner Res 1998,13:9-1343
16. Langlois JA, Rosen CJ, Visser M, Hannan MT, Harris T, Wilson PWF, et al, Association between insulin-like growth factor 1 and bone mineral density in older women and men: the Framingham Heart Study. J Clin Endocrinol Metab 1998,83:62-4257
17. Center JR, Nguyen TV, Sambrook PN, Eisman JA, Hormonal and biochemical parameters in the determination of osteoporosis in elderly men. J Clin Endocrinol Metab 1999,84:35-3626
18. Johansson AG, Forslund A, Hambraeus L, Blum WF, Ljunghall S, Growth hormone dependent insulin- like growth factor binding protein is a major determinant of bone mineral density in healthy men. J Bone Miner Res 1994,9:21-915
19. Gillberg P, Olofsson H, Mallmin H, Blum WF, Ljunghall S, Nilsson AG, Bone mineral density in femoral neck is positively correlated to circulating insulin-like growth factor (IGF-1) and IGF-binding protein (IGFBP)-3 in Swedish men. Calcif Tissue Int 2002,70:9-22
20. , 20. Szulc P, Joly Pharaboz MO, Marchand F, Delmas PD. Insulin like growth factor 1 is a determinant of hip bone mineral density in men less than 60 years of age: MINOS study. Calcif Tissue Int 2004:74::9-322
21. Sugimoto T, Nishiyama K, Kuribayashi F, Chihara K, Serum levels of insulin-like growth factor (IGF) 1, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures. J Bone Miner Res 1997,12:9-1272
22. Pfeilschifter J, Scheidt-Nave C, Leidig-Bruckner G, Woitge HW, Blum WF, Wuster C, et al, Relationship between circulating insulin like growth factor components and sex hormones in a population-based sample of 50 to 80 year old men and women. J Clin Endocrinol Metab 1996,81:40-2534
23. Amin S, Lawrence Riggs B, Atkinson EJ, Oberg AL, Melton LJ, Khosla S, A potentially deleterious role of IGFBP-2 on bone density in aging men and women. Journal of Bone and Mineral Research 2004,19:83-1075
24. Bilezikian JP, Osteoporosis in men. J Clin Endocrinol Metab 1999,84:4-3431
25. Kanis JL, Melton LS, Christiansen C, Johnston CC, Khaltaev N, The diagnosis of osteoporosis. J Bone Miner Res 1994,9:41-1137
26. Reed BY, Zerwekh JE, Sakhaee K, Breslau NA, Gottschalk F, Pak CYC, Serum IGF-1 is low and correlated with osteoblastic surface in idiopathic osteoporosis. J Bone Miner Res 1995,10:24-1218
27. Ljunghall S, Johansson AG, Burnan P, Kampe O, Lindh E, Karlsson FA, Low plasma levels of insulin like growth factor 1 (IGF) in male patients with idiopathic osteoporosis. J Intern Med 1992,232
28. Janssen JA, Burger H, Stolk RP, Grobbee DE, de Jong FH, Lamberts SW, et al, Gender –specific relationship between serum free and total IGF-1 and bone mineral density in elderly men and women. Eur J Endocrinol 1998,138:32-627
29. Krassas GE, Papadopoulou PH, Koliakos G, Growth hormone, insulin growth factor-1, and IGF binding protein-3 axis relationship with bone mineral density among healthy men. Archives of Andrology 2003,49:9-191
30. Gürlek A, Gedik O, Endogenous sex steroid, GH and IGF-1 levels in normal elderly men: Relationship with bone mineral density and markers of bone tornover. J Endocrinol Invest 2001,24:14-408
31. Johansson AG, Eriksen EF, Lindh E, Langdahl B, Blum WF, Lindahl A, et al, Reduced serum levels of the growth hormone-dependent insulin like growth factor binding protein and a negative bone balance at the level of individual remodeling units in idiopathic osteoporosis in men. J Clin Endocrinol Metab 1997,82:8-2795
32. Rucker D, Ezzat S, Diamandi A, Khosravi J, Hanley DA, IGF-1 and testosterone levels as predictors of bone mineral density in healthy, community-dwelling men. Clinical Endocrinology 2004,60-491